Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export andsupplier ofDoxorubicin Hydrochloride Injectionfrom Surat, Gujarat, India. Doxorubicin Hydrochloride Injection used to treat cancer.
Tags: Doxorubicin Hydrochloride Injection manufacturer, Doxorubicin HydrochlorideInjection exporter, Doxorubicin Hydrochloride Injection supplier,and Doxorubicin Hydrochloride Injection, whogmp approved Doxorubicin HydrochlorideInjection manufacturer and supplier, Doxorubicin Hydrochloride Injectiondistributor, Doxorubicin Hydrochloride Injection shipper, Doxorubicin HydrochlorideInjection 25 ml Doxorubicin Hydrochloride Injection 25mlsupplier,Doxorubicin Hydrochloride Injection 25 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceDoxorubicinHydrochloride Injection export to USA, Canada, Germany, Europe, France, Ghana,Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru,Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia,Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Targeted Cancer TreatmentDoxorubicin Hydrochloride Injection offers a reliable approach to combat various malignancies like breast, ovarian, leukemia, and lymphoma. Its proven efficacy and compliance with USP standards ensure patients and healthcare professionals receive a potent and consistent therapeutic option.
Quality and CompatibilityThis formulation is compatible with common infusion solutions, such as 0.9% sodium chloride and 5% dextrose. The clear red, odorless solution meets strict quality controls and is packaged in convenient vial sizes with secure flip-top caps for easy storage and transport.
Safety and MonitoringProper administration of Doxorubicin Hydrochloride Injection involves IV use only by a qualified professional. Regular monitoring of heart function and vigilance against extravasation are critical to minimize risks and maintain patient safety throughout treatment.
FAQ's of Doxorubicin Hydrochloride Injection:
Q: How is Doxorubicin Hydrochloride Injection administered?
A: This injection is administered intravenously (IV), meaning it is infused directly into a vein by a healthcare professional. Dosage and duration depend on the specific cancer being treated and patient factors.
Q: What precautions are needed during treatment with Doxorubicin Hydrochloride Injection?
A: Key precautions include closely monitoring heart function and ensuring the injection does not leak outside the vein (extravasation), as this can cause local tissue damage.
Q: When is this medication typically prescribed?
A: It is prescribed by oncologists for the treatment of cancers such as breast cancer, ovarian cancer, leukemia, and lymphoma, usually as part of a comprehensive chemotherapy regimen.
Q: Where should Doxorubicin Hydrochloride Injection be stored before use?
A: The injection should be stored in a cool, dry place, away from direct light and moisture, to ensure product stability and efficacy. Always keep it out of reach of children.
Q: What are the main benefits of using Doxorubicin Hydrochloride Injection?
A: This medication offers a potent and well-studied option for treating various cancers, with consistent efficacy when used as directed and according to clinical guidelines.
Q: Is this injection compatible with all infusion solutions?
A: Doxorubicin Hydrochloride Injection is compatible with commonly used infusion solutions such as 0.9% sodium chloride and 5% dextrose, which makes preparation and administration flexible for clinical settings.